Toward Social Implementation of Solutions to “Make it Real”
Infection Issues in Various Situations
Utilizing the wide range of technologies we possess, we promote unique social implementation in measures against infection from a broad perspective.
The power of chemistry abounds with infinite potential. We have noticed that there are many infection viruses in the world due to the COVID-19 pandemic. We contribute to infection countermeasures through production technology that can scale up our small molecule pharmaceuticals, and quality control management and assurance skills as well as our accumulated knowledge of and technologies for the production of biopharmaceuticals from microorganisms, such as proteins and plasmid DNA.
Demonstrating the Function of Infection Initiative Team
We have launched the Infection Initiative Team, which promotes R&D of infection control measures, aiming to resolve the infection issues, including the global COVID-19, and are taking wide range of measures to resolve the global issue of COVID-19 such as manufacturing PCR test kits, PCR test reagents, the manufacturing of DNA vaccine (*1) intermediates, and small molecule pharmaceuticals intermediates.
*1 A vaccine whereby introducing into the body plasmid DNA encoded with proteins from a part of the targeted pathogens (without using any dangerous pathogens), the proteins are produced within the body, giving immunity against said pathogens.
Toward Further Evolution
We have started joint research with the de Duve Institute of the University of Louvain (UCLouvain), Belgium to develop innovative production technologies for vaccines and biopharmaceuticals for viral infections. In addition, we have developed technology to easily test for Mycobacterium abscess complex (MABC) (*2), which is a refractory respiratory infection through joint research with the National Institute of Infectious Diseases, and started to commercialize the test kits since June 2021.
We are also actively developing solutions for social issues such as Kaneka Ubiquinol™ and probiotics that activate the immune function of cells, and materials used in hygiene gloves.
In the future, we will prepare for unknown viruses and further evolve our solutions while anticipating the times with the power of “chemistry” cultivated in the countermeasures against COVID-19 infections.
*2 Abscessus pulmonary disease: The disease has increased rapidly in recent years, and has infected several thousand people in Japan. Symptoms are similar to those of tuberculosis and pneumonia, including cough, phlegm, bloody phlegm, night sweats, weight loss, and fatigue.
Prevention of Infections and Hygiene Measures in Supply Chain
With the spread of COVID-19 infections, the prevention of infections for medical professionals has become a social issue. With the growing demand for ultra-thin gloves around the world, mainly for medical and food products, we continue to provide a stable supply of paste PVC resin as a material for hygiene gloves, contributing to prevention of infections and hygiene measures.
With the start of COVID-19 vaccination, TACPack™, a temperature controlled package solution material for safely transporting COVID-19 vaccines, has started to be adopted by national and local governments.
TACPack™ is a product that can maintain a temperature controlled object to be transported in a wide temperature range, and contributes not only to the transportation of vaccines but also to the transportation of various products such as medical devices, PCR test kits, chemicals, precision machinery, and cells.
Various Wellness Solutions by ALL KANEKA
The Kaneka Group has solutions in various fields. ALL KANEKA supports your healthy life by embodying technologies and ideas that will open up the future, not only for measures against infections, but also for maintaining wellness and prognosis.
Infection Issues in Various Situations
